Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1

Biochemical and Biophysical Research Communications

Volumn 444, Issue 3, 2014, Pages 427-432

  Dong, Yinying ^a   Xie, Xiaoying ^a   Wang, Zhiming ^a   Hu, Chao ^b   Zheng, Qiongdan ^a   Wang, Yaohui ^c   Chen, Rongxin ^a   Xue, Tongchun ^a   Chen, Jie ^a   Gao, Dongmei ^a   Wu, Weizhong ^a   Ren, Zhenggang ^a   Cui, Jiefeng ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Hepatocellular carcinoma; Integrin 1; Matrix stiffness; Vascular endothelial growth factor

Indexed keywords

HEPATOCELLULAR CARCINOMA; INTEGRIN Β1; MATRIX STIFFNESS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANIMALS; ANTIGENS, CD29; ANTIGENS, CD31; COLLAGEN TYPE I; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; LIPOXYGENASE; LIVER NEOPLASMS, EXPERIMENTAL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED BUF; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84894203352     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.079     Document Type: Article

References (44)

1. S. Aznavoorian, A.N. Murphy, and William G. Stetler-Stevenson et al. Molecular aspects of tumor cell invasion and metastasis Cancer 71 1993 1368 1383
2. D. Ribatti, A. Vacca, and B. Nico et al. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma Cancer Treat. Rev. 32 2006 437 444
3. P. Mignatti, and D.B. Rifkin Biology and biochemistry of proteinases in tumor invasion Physiol. Rev. 73 1993 161 195
4. Y.H. Wang, Y.Y. Dong, and W.M. Wang et al. Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines J. Exp. Clin. Cancer Res. 32 2013 51
5. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
6. V. Hernandez-Gea, S. Toffanin, and S.L. Friedman et al. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma Gastroenterology 144 2013 512 527
7. J. Folkman Proceedings: tumor angiogenesis factor Cancer Res. 34 1974 2109 2113
8. S. Coulon, F. Heindryckx, and A. Geerts et al. Angiogenesis in chronic liver disease and its complications Liver Int. 31 2011 146 162
9. D. Fukumura, T. Gohongi, and A. Kadambi et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability Proc. Natl. Acad. Sci. USA 98 2001 2604 2609
10. B. Kigel, N. Rabinowicz, and A. Varshavsky et al. Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling Blood 118 2011 4285 4296
11. M. Hollborn, C. Stathopoulos, and A. Steffen et al. Positive feedback regulation between MMP-9 and VEGF in human RPE cells Invest. Ophthalmol. Vis. Sci. 48 2007 4360 4367
12. L. Zou, H. Lai, Q. Zhou, and F. Xiao Lasting controversy on ranibizumab and bevacizumab Theranostics 1 2011 395 402
13. R.M. Loureiro, and P.A. D'Amore Transcriptional regulation of vascular endothelial growth factor in cancer Cytokine Growth Factor Rev. 16 2005 77 89
14. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
15. H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J. Clin. Oncol. 20 2002 4368 4380
16. D. Fukumura, S. Kashiwagi, and R.K. Jain The role of nitric oxide in tumour progression Nat. Rev. Cancer 6 2006 521 534
17. K. Daskalow, N. Rohwer, and E. Raskopf et al. Role of hypoxia-inducible transcription factor 1alpha for progression and chemosensitivity of murine hepatocellular carcinoma J. Mol. Med. (Berl) 88 2010 817 827
18. S. Dhup, R.K. Dadhich, and P.E. Porporato et al. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis Curr. Pharm. Des. 18 2012 1319 1330
19. G. Fattovich, T. Stroffolini, and I. Zagni et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 Suppl 1 2004 S35 S50
20. R. Masuzaki, R. Tateishi, and H. Yoshida et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography Hepatology 49 2009 1954 1961
21. J. Schrader, T.T. Gordon-Walker, and R.L. Aucott et al. Matrix stiffness modulates proliferation, chemotherapeutic response and dormancy in hepatocellular carcinoma cells Hepatology 53 2011 1192 1205
22. G. Zhao, J. Cui, and Q. Qin et al. Mechanical stiffness of liver tissues in relation to integrin β1 expression may influence the development of hepatic cirrhosis and hepatocellular carcinoma J. Surg. Oncol. 102 2010 482 489
23. R.J. Pelham Jr., and Y.I. Wang Cell locomotion and focal adhesions are regulated by substrate flexibility Proc. Natl. Acad. Sci. USA 94 1997 13661 13665
24. Y. Li, B. Tian, and J. Yang et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics J. Cancer Res. Clin. Oncol. 130 2004 460 468
25. Y. Mu, P. Liu, and G. Du et al. Action mechanism of Yi Guan Jian Decoction on CCl4 induced cirrhosis in rats J. Ethnopharmacol. 121 2009 35 42
26. V.W. Wong, J. Vergniol, and G.L. Wong et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease Am. J. Gastroenterol. 107 2012 1862 1871
27. A.X. Zhu, D.G. Duda, and D.V. Sahani et al. HCC and angiogenesis: possible targets and future directions Nat. Rev. Clin. Oncol. 8 2011 292 301
28. Y.C. Shen, C. Hsu, and A.L. Cheng Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives J. Gastroenterol. 45 2010 794 807
29. M. Minata, K.H. Harada, and M. Kudo et al. The prognostic value of vascular endothelial growth factor in hepatocellular carcinoma for predicting metastasis after curative resection Oncology 84 Suppl. 1 2013 75 81
30. Y.Y. Wu, L. Chen, and G.L. Wang et al. Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF J. Mol. Histol. 44 2013 433 445
31. Z.F. Yang, and R.T. Poon Vascular changes in hepatocellular carcinoma Anat. Rec. (Hoboken). 291 2008 721 734
32. K. Xie, D. Wei, and Q. Shi et al. Constitutive and inducible expression and regulation of vascular endothelial growth factor Cytokine Growth Factor Rev. 15 2004 297 324
33. H. Tanaka, M. Yamamoto, and N. Hashimoto et al. Hypoxia-independent overexpression of hypoxia- inducible factor 1alpha as an early change in mouse hepatocarcinogenesis Cancer Res. 66 2006 11263 11270
34. H.D. Skinner, J.Z. Zheng, and J. Fang et al. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling J. Biol. Chem. 279 2004 45643 45651
35. Y. Huang, K. Hua, and X. Zhou et al. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma Cell Res. 18 2008 780 791
36. Y. Tang, M.T. Nakada, and P. Rafferty et al. Regulation of vascular endothelial growth factor expression by EMMPRIN via thePI3K-Akt signaling pathway Mol. Cancer Res. 4 2006 371 377
37. R. Munagala, F. Aqil, and R.C. Gupta Promising molecular targeted therapies in breast cancer Indian J. Pharmacol. 43 2011 236 245
38. A.D. Bershadsky, N.Q. Balaban, and B. Geiger Adhesion-dependent cell mechanosensitivity Annu. Rev. Cell Dev. Biol. 19 2003 677 695
39. D.T. Butcher, T. Alliston, and V.M. Weaver A tense situation: forcing tumor progression Nat. Rev. Cancer 9 2009 108 122
40. S. Huang, and D.E. Ingber Cell tension, matrix mechanics and cancer development Cancer Cell 8 2005 175 176
41. M.J. Paszek, N. Zahir, and K.R. Johnson et al. Tensional homeostasis and the malignant phenotype Cancer Cell 8 2005 241 254
42. W. Guo, and F.G. Giancotti Integrin signalling during tumor progression Nat. Rev. Mol. Cell Biol. 5 2004 816 826
43. M. Delcommenne, and C.H. Streuli Control of integrin expression by extracellular matrix J. Biol. Chem. 270 1995 26794 26801
44. K.R. Levental, H. Yu, L. Kass, J.N. Lakins, and M. Egeblad Matrix crosslinking forces tumor progression by enhancing integrin signaling Cell 139 2009 891 906